Navigation Links
Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH)
Date:12/10/2007

-Patients treated with Lovenox(R) (enoxaparin sodium injection) were also

less likely to be readmitted to hospital within 90 days-

BRIDGEWATER, N.J., Dec 10 /PRNewswire-FirstCall/ -- Sanofi-aventis announced today the results of a study that demonstrated total hospital direct medical costs associated with VTE treatment are reduced by $550 per patient when they were treated with the use of low-molecular weight heparin (LMWH) vs. unfractionated heparin (UFH) with 97.3% of LMWH patients receiving Lovenox. Patients who received LMWH were also less likely to be readmitted to the hospital with a VTE recurrence within 90 days. The findings were presented at American Society of Hematology Annual Meeting (ASH) in Atlanta, GA.

The current healthcare and economic burden of venous thromboembolism (VTE) in U.S. hospitals is significant. In patients with confirmed VTE, evidence- based guidelines recommend treatment for a minimum of five days with either a low-molecular weight heparin (LMWH, such as Lovenox) or UFH. However, in the real-world practice, the total hospital direct medical costs and VTE-related readmission rates of these VTE treatment regimens are not clear.

A retrospective real-world cohort study examining discharge and billing records from the Premier Perspective(TM) database included discharges of patients less than 18 years old and with a primary diagnosis of VTE from January 2003 through June 2005. Only VTE patients who were treated with either LMWH or UFH were included in the study. Total hospital direct medical costs associated with VTE treatment (including drug costs, hospital costs, and professional costs) were quantified and compared for patients receiving UFH and LMWH. Furthermore, VTE-related readmission rates at days 30 and 90 post- discharge were compared for both patient cohorts. Total direct medical costs (US $) were compared using multivariate statistics, adjusting for patient and hospital characteristics. Logistic
'/>"/>

SOURCE sanofi-aventis
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2010)... February 9 Debiopharm Group,(Debiopharm), ... with,a focus on the development of prescription ... the signature of an exclusive licence agreement ... of Debio 025,(alisporivir), a selective, first-in-class cyclophilin ... (HCV) effect. The product is currently in ...
(Date:2/8/2010)... Ore. , Feb. 8 ... to a steady increase in the use and ... such as arthritis and psoriasis. This has led ... overall drug costs and medication coverage being spread ... introduced a new solution with Medication Cost Integration ...
(Date:2/8/2010)... A.W.A.R.E., Initiative Drives Awareness for Improving the Safety ... FLORHAM PARK, N.J. , Feb. 8 ... launch of a new initiative to promote safer ... hospitals based on the American Society for Parenteral ... ,, The "Be A.W.A.R.E." campaign is designed to ...
Breaking Medicine Technology:Debiopharm Group Grants an Exclusive Licence for the Development, Manufacture and Commercialisation of Debio 025 2Debiopharm Group Grants an Exclusive Licence for the Development, Manufacture and Commercialisation of Debio 025 3RegenceRx Leads the Industry With Introduction of Medication Cost Integration 2RegenceRx Leads the Industry With Introduction of Medication Cost Integration 3Nestle HealthCare Nutrition and HealthCare Professionals Join Forces to Improve Patient Safety 2Nestle HealthCare Nutrition and HealthCare Professionals Join Forces to Improve Patient Safety 3Nestle HealthCare Nutrition and HealthCare Professionals Join Forces to Improve Patient Safety 4Nestle HealthCare Nutrition and HealthCare Professionals Join Forces to Improve Patient Safety 5DIA Annual Meeting Attendees Invited to Participate in Electronic Data Capture 28EDC 29 Clinical Trial Survey 4626 1DIA Annual Meeting Attendees Invited to Participate in Electronic Data Capture 28EDC 29 Clinical Trial Survey 4626 2Unspoken memories of Holocaust survivors find silent and nonpathological expression 49625 1Unspoken memories of Holocaust survivors find silent and nonpathological expression 49625 2Toxic molecule may help birds see north and south 8951 1Toxic molecule may help birds see north and south 8951 2
... is pleased to announce its involvement in a five-year clinical ... TH,s collaborator, Duke University , was the recipient of ... by the foundation in 2009 to further the development of ... Komen for the Cure(R) is a nonprofit organization dedicated to ...
... New Health Sciences Inc. (NHSi) has won ... Heart, Lung and Blood Institute of the National Institutes ... The project aims to develop the Hemanext Anaerobic ... therapy and extends the shelf life of blood for ...
Other Medicine Technology:Theranostics Health Announces Involvement with Major Academic Medical Center in Study Funded by Susan G. Komen for the Cure(R) 2Theranostics Health Announces Involvement with Major Academic Medical Center in Study Funded by Susan G. Komen for the Cure(R) 3Bethesda-Based NHSi Wins $2M Grant for Blood Technology 2Bethesda-Based NHSi Wins $2M Grant for Blood Technology 3
(Date:2/9/2010)... the Ireland Cancer Center of University Hospitals (UH) Case ... to a new standard of care for patients with ... February issue of Clinical Cancer Research, the ... Triapine, was well tolerated in combination with standard-of-care cisplatin ... This regimen provided both significant reduction in cancer disease ...
(Date:2/9/2010)... Problem-Riddled Health Freedom Act Could See Idaho Lose $1.6 ... BOISE, Idaho , Feb. 9 ... to oppose a non-existent federal health care law, the long-term ... come.  AARP is calling the Idaho Health Freedom Act (House ... if signed into law, could see Idaho lose ...
(Date:2/9/2010)... The most comprehensive study to date of secondhand smoke ... the journal Addiction . The study, carried out ... Health, reveals that exposure to household secondhand smoke among ... The researchers wanted to find out if there were ... by children in private households, and whether those levels ...
(Date:2/9/2010)... Consuming two or more soft drinks per week increased ... compared with individuals who did not consume soft drinks, ... & Prevention , a journal of the American Association ... cancer remains one of the most deadly; only 5 ... later. , Mark Pereira, Ph.D., senior author on the ...
(Date:2/9/2010)... infants born prematurely in the US, according to data ... These findings were reported at the 30th Annual Meeting ... also were published in the latest issue of the ... Researchers reported that CP is associated with inflammation of ... is more common in premature births from preterm labor ...
Breaking Medicine News(10 mins):Health News:Idaho House Moves State Closer to Health Care Disaster 2Health News:Idaho House Moves State Closer to Health Care Disaster 3Health News:Idaho House Moves State Closer to Health Care Disaster 4Health News:Exposure to secondhand smoke among children in England has declined since 1996 2Health News:Soft drinks may increase risk of pancreatic cancer 2Health News:Incidence of cerebral palsy on rise in US 2
... Nationwide,Health Properties, Inc. (NYSE: NHP ) announced ... share dividend on the company,s common stock,that will be ... on August,15, 2008., In addition, NHP,s Board of ... B cumulative convertible preferred stock that will,be paid on ...
... Not That! Authors Grade 43 National Chains; 6 Receive ... kids, menus are most likely to,make your children fat? ... differences among America,s favorite fast-food and sit-down,chain restaurants, according ... NOT,THAT! For Kids. Co-authors David Zinczenko and Matt Goulding ...
... Anpath Group, Inc.,(OTC Bulletin Board: ANPG), today announced that ... Gilroy have been appointed to its board of,directors and ... Mr. Boyer is the Chief Financial Officer of StrikeIron,Inc., ... Internet and Mr.,Gilroy is the founder and Managing Director ...
... 1 Conseco, Inc. (NYSE:,CNO) announced today that:, ... president of Conseco Insurance,Group (CIG), including Worksite Operations ... as executive vice president of operations,for Conseco, replaces ... reasons., -- Russell M. Bostick has been ...
... nutritional supplement no substitute for old-fashioned hard work, ... -- Taking creatine doesn,t improve exercise outcomes in ... a U.K. study reports. , Creatine is ... performance and muscle strength. This study included 100 ...
... that builds on healthcare reform proposal, WASHINGTON, ... today by Senators Max Baucus (D-MT) and Kent ... officer of the Blue,Cross and Blue Shield Association ... Senators Baucus and Conrad for introducing legislation that,would ...
Other Medicine News:Health News:NHP Declares Quarterly Cash Dividends on Common Stock and Series B Preferred Stock 2Health News:NHP Declares Quarterly Cash Dividends on Common Stock and Series B Preferred Stock 3Health News:America's Worst Restaurants for Kids Revealed 2Health News:America's Worst Restaurants for Kids Revealed 3Health News:America's Worst Restaurants for Kids Revealed 4Health News:America's Worst Restaurants for Kids Revealed 5Health News:Anpath Group, Inc. Announces Appointments of David V. Gilroy and Paul A. Boyer to Board of Directors 2Health News:Anpath Group, Inc. Announces Appointments of David V. Gilroy and Paul A. Boyer to Board of Directors 3Health News:Anpath Group, Inc. Announces Appointments of David V. Gilroy and Paul A. Boyer to Board of Directors 4Health News:Stecher Named President of Conseco Insurance Group; Bostick to Lead Integrated IT and Operations Group at Conseco 2Health News:Creatine Has Negligible Effect on COPD Exercise Rehab 2Health News:BCBSA: Time Is Right for Comparative Effectiveness Research Institute 2
This product is for the lower body and uses a Convective Warming System which is both soft and comfortable. Constructed of 2-ply material consisting of polyethylene film inner layer and non-woven out...
The torso blanket is designed to affix to the lower abdominal area and cover the upper half of the body....
The fabric is antistatic and non-linting and is both oil and water repellent.These superior blankets are an environmental friendly alternative to disposable blankets....
CritiCool™ offers precise cooling to the programmed target temperature by applying temperature control algorithm....
Medicine Products: